Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Nonino

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Journal of Clinical Epidemiology|December 20, 2023
GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine ListsThomas Piggott, Lorenzo Moja, Kristina Jenei, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 16, 2020
Risk of Hospitalization and Death for COVID-19 in People with Parkinson's Disease or ParkinsonismLuca Vignatelli, Corrado Zenesini, Laura M B Belotti, et al.
Frontiers in Neurology|June 2, 2022
The Indirect Impact of COVID-19 on Major Clinical Outcomes of People With Parkinson's Disease or Parkinsonism: A Cohort StudyLuca Vignatelli, Flavia Baccari, Laura Maria Beatrice Belotti, et al.
Multiple Sclerosis and Related Disorders|March 4, 2022
Identifying unanswered questions and setting the agenda for future systematic research in Multiple Sclerosis. A worldwide, multi-stakeholder Priority Setting projectMaria Grazia Celani, Francesco Nonino, Kathryn Mahan, et al.
European Journal of Neurology|July 16, 2022
Risk of SARS-CoV-2 infection, hospitalization and death for COVID-19 in people with Parkinson's disease or parkinsonism over a 15-month period: a cohort studyCorrado Zenesini, Luca Vignatelli, Laura Maria Beatrice Belotti, et al.
European Journal of Neurology|January 31, 2025
Causes of hospitalization and mortality in persons with epilepsy: The EpiLink Bologna cohort, ItalyLorenzo Muccioli, Corrado Zenesini, Laura Licchetta, et al.
Annals of Internal Medicine|March 16, 2026
New GRADE Evidence-to-Decision Framework for Pairwise and Multiple Comparisons (GRADE Guidance 45)Jessica Beltran, Itziar Etxeandia-Ikobaltzeta, Thomas Piggott, et al.
BMJ Open|July 25, 2025
Development of a core outcome set for the trials of complementary therapies in people with multiple sclerosis: international survey and consensus meetingsJesus Lopez-Alcalde, Anna K Tietjen, Yuqian Yan, et al.
Multiple Sclerosis and Related Disorders|December 2, 2025
Recommendations for the use of off-label rituximab for the treatment of multiple sclerosis in low-resource settingsNick Rijke, Bassem I Yamout, Deanna Saylor, et al.
Cochrane Evidence Synthesis and Methods|January 23, 2026
Methods of Engaging Interest-Holders in Healthcare Evidence Syntheses: A Scoping ReviewAlex Todhunter-Brown, Jennifer Petkovic, Christine Chang, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Journal of Clinical Epidemiology|December 20, 2023
GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine ListsThomas Piggott, Lorenzo Moja, Kristina Jenei, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 16, 2020
Risk of Hospitalization and Death for COVID-19 in People with Parkinson's Disease or ParkinsonismLuca Vignatelli, Corrado Zenesini, Laura M B Belotti, et al.
Frontiers in Neurology|June 2, 2022
The Indirect Impact of COVID-19 on Major Clinical Outcomes of People With Parkinson's Disease or Parkinsonism: A Cohort StudyLuca Vignatelli, Flavia Baccari, Laura Maria Beatrice Belotti, et al.
Multiple Sclerosis and Related Disorders|March 4, 2022
Identifying unanswered questions and setting the agenda for future systematic research in Multiple Sclerosis. A worldwide, multi-stakeholder Priority Setting projectMaria Grazia Celani, Francesco Nonino, Kathryn Mahan, et al.
European Journal of Neurology|July 16, 2022
Risk of SARS-CoV-2 infection, hospitalization and death for COVID-19 in people with Parkinson's disease or parkinsonism over a 15-month period: a cohort studyCorrado Zenesini, Luca Vignatelli, Laura Maria Beatrice Belotti, et al.
European Journal of Neurology|January 31, 2025
Causes of hospitalization and mortality in persons with epilepsy: The EpiLink Bologna cohort, ItalyLorenzo Muccioli, Corrado Zenesini, Laura Licchetta, et al.
Annals of Internal Medicine|March 16, 2026
New GRADE Evidence-to-Decision Framework for Pairwise and Multiple Comparisons (GRADE Guidance 45)Jessica Beltran, Itziar Etxeandia-Ikobaltzeta, Thomas Piggott, et al.
BMJ Open|July 25, 2025
Development of a core outcome set for the trials of complementary therapies in people with multiple sclerosis: international survey and consensus meetingsJesus Lopez-Alcalde, Anna K Tietjen, Yuqian Yan, et al.
Multiple Sclerosis and Related Disorders|December 2, 2025
Recommendations for the use of off-label rituximab for the treatment of multiple sclerosis in low-resource settingsNick Rijke, Bassem I Yamout, Deanna Saylor, et al.
Cochrane Evidence Synthesis and Methods|January 23, 2026
Methods of Engaging Interest-Holders in Healthcare Evidence Syntheses: A Scoping ReviewAlex Todhunter-Brown, Jennifer Petkovic, Christine Chang, et al.
Pageof 5